Etrasimod
Etrasimod (APD334) is a potent, selective and orally available antagonist of the sphingosine-1-phosphate-1 (S1P1) receptor with an IC50 value of 1.88 nM in CHO cells.
Product Specifications
CAS Number
1206123-37-6
Product Name Alternative
APD334
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
LPL Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/Etrasimod.html
Purity
99.91
Solubility
DMSO : 116.67 mg/mL (ultrasonic)
Smiles
FC(F)(F)C1=CC(COC2=CC=C(NC3=C4CC[C@@H]3CC(O)=O)C4=C2)=CC=C1C5CCCC5
Molecular Formula
C26H26F3NO3
Molecular Weight
457.48
Precautions
H302, H315, H319, H335
References & Citations
[1]Buzard DJ, et al. Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor. ACS Med Chem Lett. 2014 Nov 4;5 (12) :1313-7.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS7081885 Inquire
Recombinant Rat Calcium release-activated calcium channel protein 1 (Orai1), partial
Sign In for Pricing
View Details 
A57587-100 100 µL
Igg Heavy Chain Polyclonal Antibody, Biotin Conjugated
Sign In for Pricing
View Details